基本属性 生物活性靶点体外研究体内研究 用途与合成方法 供应商 供应信息

CITCO

CITCO

中文名称:CITCO
英文名称:CITCO
CAS号:338404-52-7
分子式:C19H12Cl3N3OS
分子量:436.74
EINECS号:
Mol文件:338404-52-7.mol
CITCO 结构式

CITCO 性质

密度 1.48±0.1 g/cm3(Predicted)
储存条件 -20°C
溶解度 DMSO:28 mg/mL,可溶
形态 固体
酸度系数(pKa) 4.05±0.40(Predicted)

CITCO 用途与合成方法

CITCO 是一种组成型雄甾烷 (Constitutive androstane) 受体激动剂,抑制脑肿瘤干细胞 (BTSCs) 的生长和扩增。CITCO 是一种咪唑并噻唑衍生物,其作为人 CAR 的选择性激动剂起作用。CITCO 对于孕烷 X 受体 (PXR) 的 EC50 为 49 nM,并且对其他核受体没有活性。

CAR, PXR

CITCO (1-50 μM; 48 hours) results in a dose-dependent inhibition of viable cell count and proliferation in both T98G and U87MG glioma and BTSCs.
CITCO (2.5, 5 μM; 48 hours) induces cell cycle arrest differentially in different BTSCs in culture, but not in normal astrocytes.
CITCO (2.5-10 μM; 48 hours) induces apoptosis in BTSCs in culture in dose dependently, but not in normal astrocytes.
CITCO (0-25 μM; 48 hours) causes the T98G and U87MG glioma and BTSCs expressing very low levels of CAR protein that increased significantly.

Cell Proliferation Assay

Cell Line: T98G, U87MG, DB29 and DB33 human glioma cells, astrocytes
Concentration: 1, 2.5, 5, 10, 25, 50 μM
Incubation Time: 48 hours
Result: Resulted in a dose-dependent inhibition of viable cell count and proliferation.

Cell Cycle Analysis

Cell Line: The T98G, U87MG, DB29 and DB33 glioma cells
Concentration: 2.5, 5 μM
Incubation Time: 48 hours
Result: Induced cell cycle arrest differentially in different BTSCs in culture.

Apoptosis Analysis

Cell Line: The T98G, U87MG, DB29 and DB33 glioma cells
Concentration: 2.5, 5 or 10 μM
Incubation Time: 48 hours
Result: Increased the levels of Annexin V-positive apoptotic cells in dose dependently.

Western Blot Analysis

Cell Line: T98G, U87MG, DB29 and DB33 glioma cells
Concentration: 0 to 25 μM
Incubation Time: 48 hours
Result: The T98G, U87MG glioma and BTSCs expressed very low levels of CAR protein that increased significantly.

CITCO (intraperitoneal; on days 22, 24, 26, 30 and 36) with 25 μg results a significant decrease in tumour growth, which further decreases to an undetectable level after treatment with 100 μg CITCO .

Animal Model: Six- to eight-week-old male athymic nude mice
Dosage: 25 or 100 μg
Administration: Intraperitoneal; on days 22, 24, 26, 30 and 36
Result: Decreased tumour growth.

安全信息

危险品标志Xi
危险类别码36/37/38
安全说明26-36
WGK Germany3

CITCO供应商 更多

上海喀露蓝科技有限公司
联系电话: 18149758185
产品介绍:
英文名称:CITCO
CAS:338404-52-7
纯度:98%
包装信息:1g;10g;100g
Sigma-Aldrich西格玛奥德里奇(上海)贸易有限公司
联系电话:021-61415566 800-8193336
产品介绍:
英文名称:CITCO
CAS:338404-52-7
纯度:>=98% (HPLC)
包装信息:5mg
备注:C6240
上海一飞生物科技有限公司
联系电话:021-65675885 18964387627
产品介绍:
英文名称:CITCO
CAS:338404-52-7
纯度:95%
包装信息:5mg;10mg;25mg
备注:试剂级
上海瀚香生物科技有限公司
联系电话:17754423994 17754423994
产品介绍:
英文名称:CITCO
CAS:338404-52-7
纯度:98% HPLC LCMS
包装信息:100MG;1G
备注:量大优惠,现货促销
上海芮晖化工科技有限公司
联系电话:21-31433387 15618786686
产品介绍:
CAS:338404-52-7
纯度:98%
包装信息:1g;10g
备注:现货优势供应

最新发布供应信息

aladdin 阿拉丁 C288064 CITCO 338404-52-7 ≥98%(HPLC)
上海阿拉丁生化科技股份有限公司 2024-06-03